Clinical Trial Update: Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia [NA]

View source ↗

Summary

A completed clinical trial investigating hematopoietic stem cell transplantation for Dyskeratosis Congenita or Severe Aplastic Anemia has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Dyskeratosis Congenita

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Dyskeratosis Congenita, Aplastic Anemia | NA | Status: COMPLETED | Results posted: 2025-05-08